CYSTEAMINE IMPROVES THE BACTERICIDAL EFFICACY OF INTRA-CANAL MEDICAMENTS AGAINST ENTEROCOCCUS FAECALIS

Authors

  • Sanket Hans Pandey
  • Pallav Mahesh Patni
  • Pradeep Jain
  • Gauri Sanwatsarkar
  • Chinki Bardia

DOI:

https://doi.org/10.15386/cjmed-926

Keywords:

calcium hydroxide, chlorhexidine, cysteamine, Enterococcus Faecalis, triple antibiotic paste

Abstract

Aim. The aim of this study was to compare the antimicrobial efficacy of cysteamine, calcium hydroxide[Ca(OH)2], triple antibiotic paste (TAP), chlorhexidine (CHX) and their combinations against Enterococcus faecalis (E. Faecalis).

Methods. The E. Faecalis eradication capacity of cysteamine, Calcium hydroxide (Ca[OH]2), TAP, CHX, and their combinations was tested on E. Faecalis by Kirby Brauer disc diffusion method.

Results. Cysteamine in combination with TAP was able to completely eradicate E. Faecalis within 24 hours. Ca(OH)2 was unable to show its effect on E. Faecalis in the given time.

Conclusion. Cysteamine increased the E. Faecalis eradicating capacity of TAP and also showed positive results when used in combination with Ca(OH)2, which if used alone was unable to show any action in 24 hours.

Author Biographies

Sanket Hans Pandey, Madhya Pradesh Medical Science University

Conservative Dentistry and Endodontics

Pallav Mahesh Patni, Madhya Pradesh Medical Science University

Department of Conservative Dentistry and Endodontics

Pradeep Jain, Madhya Pradesh Medical Science University

Department of Conservative Dentistry and Endodontics

Gauri Sanwatsarkar, Madhya Pradesh Medical Science University

Department of Conservative Dentistry and Endodontics

Chinki Bardia, Madhya Pradesh Medical Science University

Department of Conservative Dentistry and Endodontics

Downloads

Additional Files

Published

2018-10-30

How to Cite

1.
Pandey SH, Patni PM, Jain P, Sanwatsarkar G, Bardia C. CYSTEAMINE IMPROVES THE BACTERICIDAL EFFICACY OF INTRA-CANAL MEDICAMENTS AGAINST ENTEROCOCCUS FAECALIS. Med Pharm Rep [Internet]. 2018 Oct. 30 [cited 2025 Oct. 5];91(4):448-51. Available from: https://medpharmareports.com/index.php/mpr/article/view/926

Issue

Vol. 91 No. 4 (2018)

Section

Original Research

License

The authors are required to transfer the copyright of the published paper to the journal. This is done by agreeing to sign the Copyright Assignment Form. Whenever the case, authors are also required to send permissions to reproduce material (such as illustrations) from the copyright holder.

 Creative Commons License
The papers published in the journal are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.